Christopher Charles Reynolds

LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands.

Part of LumiraDx Ltd. (Cayman Islands), LumiraDx Group Ltd. is a next generation point of care diagnostic platform that was founded in 2014. The company is based in London, UK and is transforming community-based healthcare with lab comparable results in minutes. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing by utilizing its innovative qSTAR nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations.

Part of LumiraDx Ltd. (Cayman Islands), LKM Innovations Ltd. is a British company founded in 2009 that specializes in fast lab solutions. The company is based in Stirling, UK. LKM Innovations operates as a dedicated LumiraDx business unit that supports high-complexity laboratory testing by utilizing its innovative qstar nucleic acid amplification technology in an accessible high-throughput format to leverage current molecular laboratory operations. The LumiraDx D-dimer test is an easy-to-use fluorescence immunoassay designed to rapidly quantify D-dimer levels in human whole blood and plasma at the point of care, providing lab-comparable results in minutes.

Part of LumiraDx Ltd. (Cayman Islands), LumiraDx International Ltd. is a wholesaler of pharmaceutical goods. The company is based in London, UK. LumiraDx International was founded in 2014.

Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on 2001-12-20 for $146.54 million.

Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then.

MedApps, Inc. provides mobile wireless remote patient monitoring. The company was founded by Kent E. Dicks in 2006 and is headquartered in Scottsdale, AZ.